GeneMatrix Inc. (KOSDAQ:109820)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,932.00
+1.00 (0.05%)
At close: Apr 9, 2026
Market Cap40.99B -18.1%
Revenue (ttm)4.72B -3.7%
Net Income-2.09B
EPS-123.85
Shares Out20.39M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,050
Average Volume40,252
Open1,931.00
Previous Close1,931.00
Day's Range1,905.00 - 1,935.00
52-Week Range1,891.00 - 3,835.00
Beta1.18
RSI45.65
Earnings Daten/a

About GeneMatrix

GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment. It also provides biochemical diagnostics, such as special chemistry and general chemistry, that includes semi and full auto analyer, and calibrators and contro... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2000
Employees 31
Stock Exchange KOSDAQ
Ticker Symbol 109820
Full Company Profile